Premium
ANAEMIA AND MINERAL BONE DISORDER IN CHRONIC KIDNEY DISEASE: A REVIEW OF THE CURRENT LITERATURE AND IMPLICATIONS FOR CLINICAL NURSING PRACTICE
Author(s) -
Limrick Claire,
McNicholsThomas Coral
Publication year - 2009
Publication title -
journal of renal care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.381
H-Index - 27
eISSN - 1755-6686
pISSN - 1755-6678
DOI - 10.1111/j.1755-6686.2009.00062.x
Subject(s) - medicine , secondary hyperparathyroidism , kidney disease , intensive care medicine , quality of life (healthcare) , hyperparathyroidism , disease , chronic renal failure , clinical practice , population , physical therapy , nursing , calcium , environmental health , parathyroid hormone
SUMMARY Secondary hyperparathyroidism (SHPT) is one of the factors reported to have a negative impact on anaemia of chronic kidney disease (ACKD) and its treatment. SHPT is one of the abnormalities resulting from altered bone mineral metabolism. Five possible mechanisms have been proposed as to how SHPT impacts on anaemia in this paper. Each of these mechanisms will be considered and the treatment options reviewed including the implications for erythropoietic stimulating agents (ESA) prescribing. Anaemia and SHPT are both strongly predictive of complications and death from cardiovascular events in patients with chronic kidney disease (CKD). Nursing care of this group of patients should, therefore, be holistic in order to ensure optimum management. Ways in which we can practice to enhance quality of life and outcomes in this patient population will be discussed.